518 related articles for article (PubMed ID: 24746973)
1. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
[TBL] [Abstract][Full Text] [Related]
2. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
Sundi D; Ross AE; Humphreys EB; Han M; Partin AW; Carter HB; Schaeffer EM
J Clin Oncol; 2013 Aug; 31(24):2991-7. PubMed ID: 23775960
[TBL] [Abstract][Full Text] [Related]
3. The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy.
Nocera L; Wenzel M; Collà Ruvolo C; Würnschimmel C; Tian Z; Gandaglia G; Fossati N; Chun FKH; Mirone V; Graefen M; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
World J Urol; 2022 Jan; 40(1):103-110. PubMed ID: 34436637
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival.
Bakavičius A; Drevinskaitė M; Daniūnaitė K; Barisienė M; Jarmalaitė S; Jankevičius F
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32033148
[No Abstract] [Full Text] [Related]
5. Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance.
Jeon HG; Yoo JH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM; Ferrari M; Brooks JD; Chung BI
PLoS One; 2017; 12(11):e0186026. PubMed ID: 29136019
[TBL] [Abstract][Full Text] [Related]
6. Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance.
Ha YS; Salmasi A; Karellas M; Singer EA; Kim JH; Han M; Partin AW; Kim WJ; Lee DH; Kim IY
Urology; 2013 Apr; 81(4):831-5. PubMed ID: 23465143
[TBL] [Abstract][Full Text] [Related]
7. Risk of Pathological Upgrading and Up Staging among Men with Low Risk Prostate Cancer Varies by Race: Results from the National Cancer Database.
Maurice MJ; Sundi D; Schaeffer EM; Abouassaly R
J Urol; 2017 Mar; 197(3 Pt 1):627-631. PubMed ID: 27582435
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
9. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy.
Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY
Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648
[TBL] [Abstract][Full Text] [Related]
10. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
[TBL] [Abstract][Full Text] [Related]
11. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
12. Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States.
Weiner AB; Patel SG; Eggener SE
Urol Oncol; 2015 Apr; 33(4):164.e11-7. PubMed ID: 25624093
[TBL] [Abstract][Full Text] [Related]
13. Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.
Yang DD; Mahal BA; Muralidhar V; Nezolosky MD; Vastola ME; Labe SA; Boldbaatar N; King MT; Martin NE; Orio PF; Beard CJ; Hoffman KE; Trinh QD; Spratt DE; Feng FY; Nguyen PL
Eur Urol Focus; 2019 Jan; 5(1):69-76. PubMed ID: 28753811
[TBL] [Abstract][Full Text] [Related]
14. A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease?
Schreiber D; Chhabra A; Rineer J; Weedon J; Schwartz D
Clin Genitourin Cancer; 2015 Aug; 13(4):e259-e264. PubMed ID: 25777681
[TBL] [Abstract][Full Text] [Related]
15. Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes.
Cooperberg MR; Cowan JE; Lindquist KJ; Kobayashi Y; Simko JP; Bengtsson H; Singh K; Ngo V; Avila A; Newcomb LF; Tretriakova M; Lin DW; Stone S; Carroll PR; Paris PL
Eur Urol; 2021 Jan; 79(1):141-149. PubMed ID: 33148472
[TBL] [Abstract][Full Text] [Related]
16. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.
Yamoah K; Deville C; Vapiwala N; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Kattan M; Dicker AP; Rebbeck TR
Urol Oncol; 2015 Feb; 33(2):70.e15-22. PubMed ID: 25304288
[TBL] [Abstract][Full Text] [Related]
17. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
Leapman MS; Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Walker K; Amling CL; Carroll PR; Cooperberg MR
J Urol; 2016 Nov; 196(5):1408-1414. PubMed ID: 27352635
[TBL] [Abstract][Full Text] [Related]
18. Commentary on "African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?" Sundi D, Ross AE, Humphreys EB, Han M, Partin AW, Carter HB, Schaeffer EM, Johns Hopkins University, Baltimore, MD. J Clin Oncol 2013; 31(24):2991-7. [Epub 2013 Jun 17]. doi: 10.1200/JCO.2012.47.0302.
Eggener S
Urol Oncol; 2014 Aug; 32(6):936. PubMed ID: 25087674
[TBL] [Abstract][Full Text] [Related]
19. Impact of ethnicity on surgical margins at radical prostatectomy.
Rabbani F; Yunis LH; Vora K; Eastham JA; Guillonneau B; Scardino PT; Touijer K
BJU Int; 2009 Oct; 104(7):904-8. PubMed ID: 19389008
[TBL] [Abstract][Full Text] [Related]
20. No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance.
Herkommer K; Maier N; Ankerst DP; Schiele S; Gschwend JE; Meissner VH
World J Urol; 2021 Jul; 39(7):2499-2506. PubMed ID: 33048258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
